Skip to main content
Mobile Logo in White
Desktop Logo

Newsroom

UT Health San Antonio Search/Quicklinks
  • Home
  • Education
  • Health
  • Research
  • Community
  • Campus
  • Filter News
  • News Releases
  • Home
  • Education
  • Health
  • Research
  • Community
  • Campus
  • Filter News
  • News Releases

The Pakistan Post.net: Cognition and gait speed often decline together, study shows

May 5, 2020

Do thinking and walking go hand in hand in determining the health course of senior adults? A study published by UT Health San Antonio researchers found that, indeed, the two functions often parallel each other in determining a person’s health trajectory. Read the full story.


KSAT 12: San Antonio doctor involved in remdesivir trial says FDA emergency approval is ‘very exciting’

May 4, 2020

Drs. Thomas Patterson, chief of the Division of Infectious Diseases, and Jason Bowling, Infectious Diseases, explained the implications of the FDA fast-tracking emergency authorization of the new anti-viral drug, remdesivir, as the new standard of care for hospitalized COVID-19 patients. Read and watch the full story.


Telemundo: Investigan si medicamento contra el ebola puede ayudar a tratar el COVID-19

May 1, 2020

Dr. Barbara Taylor, Infectious Diseases, was interviewed about the preliminary results of a clinical trial studying remdesivir as an anti-viral agent against COVID-19. Watch the story.


KABB: ‘Promising’ treatment for COVID-19 being tested with San Antonio patients

May 1, 2020

Dr. Thomas Patterson, chief of infectious diseases and PI of the remdesivir clinical trial site locally, discusses the promising early results of the drug in the fight against COVID-19. Read the full story.


News 4: ‘Promising’ treatment for COVID-19 being tested with San Antonio patients

May 1, 2020

Dr. Thomas Patterson, chief of infectious diseases and PI of the remdesivir clinical trial site locally, discusses the promising early results of the drug in the fight against COVID-19. Read and watch the full story.


KSAT 12: New COVID-19 drug being tested in San Antonio provides faster recovery time, fewer deaths, early results from study shows

May 1, 2020

Dr. Thomas Patterson, chief of infectious diseases and PI of the remdesivir clinical trial site locally, discusses the promising early results of the drug in the fight against COVID-19. Read and watch the full story. 


  • 1
  • 328
  • 329
  • 330
  • 331
  • 332
  • 333
  • 334
  • 335
  • 336
  • 337
  • 338
  • 393

Mission magazine

Learn about the myriad contributions being made every day by our faculty, staff, students and residents in the areas of research, academics, patient care and community service. UT Health San Antonio's magazines chronicle the extraordinary efforts made by so many in service to our community.

View the magazine

UT Health San Antonio

Newsroom

7703 Floyd Curl Drive
San Antonio, TX 78229
Map and directions
communications@uthscsa.edu
  • For media inquires
  • Read the university’s magazine, Mission

We make lives better ®

UT San Antonio Health Science Center is the academic health center of The University of Texas at San Antonio. It includes schools of medicine, dentistry, nursing, health professions, graduate biomedical sciences and public health, and a clinical enterprise called UT Health San Antonio, which conducts 2.5 million patient visits yearly.

Web Privacy | Links from websites affiliated with UT Health San Antonio’s website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a healthcare provider if you are in need of treatment.

Quicklinks

UT Health San Antonio

  • UT Health San Antonio
  • University Magazines
  • COVID-19
  • Patient Care